Substance use and psychosocial outcomes following participation in residential laboratory studies of marijuana, methamphetamine and zolpidem

American Journal of Drug and Alcohol Abuse

Volumn 32, Issue 4, 2006, Pages 589-597

  Vadhan, Nehal P ^a   Hart, Carl L ^a   Roe, Brooke ^a   Colley, Jana ^a   Haney, Margaret ^a   Foltin, Richard W ^a  

^a NONE

Author keywords

Abuse potential; Ambien; Cannabis; Drug administration; Humans; Stimulants

Indexed keywords

ALCOHOL; CANNABIS; METHAMPHETAMINE; ZOLPIDEM;

ADDICTION SEVERITY INDEX; ADULT; ALCOHOL CONSUMPTION; ARTICLE; ETHICS; FEMALE; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OUTCOME ASSESSMENT; PSYCHOSOCIAL ENVIRONMENT; RATING SCALE; RESEARCH; RISK ASSESSMENT; SUBSTANCE ABUSE;

ALCOHOLISM; COSTS AND COST ANALYSIS; DOPAMINE AGENTS; HUMANS; HYPNOTICS AND SEDATIVES; MARIJUANA ABUSE; METHAMPHETAMINE; NEW YORK; PYRIDINES; SOCIAL SUPPORT; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 33845334144     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.1080/00952990600920565     Document Type: Article

References (16)

1. Fischman MW, Johanson CE. Ethical and practical issues involved in behavioral pharmacology research that administers drugs of abuse to human volunteers. Behav Pharmacol 1998; 9(7):479-498.
2. Nahas GG. The experimental use of cocaine in human subjects. Bulletin on Narcotics 1990; 42(1):57-62.
3. Mendelson JH. Protection of participants and experimental design in clinical abuse liability testing. British Journal of Addiction 1991; 86(12):1543-1548.
4. Modell JG, Glaser FB, Mountz JM. The ethics and safety of alcohol administration in the experimental setting to individuals who have chronic, severe alcohol problems. Alcohol & Alcoholism 1993; 28(2):189-197.
5. Elman I, Krause S, Karlsgodt K, Schoenfeld DA, Gollub RL, Breiter HC, Gastfriend DR. Clinical outcomes following cocaine infusion in nontreatment-seeking individuals with cocaine dependence. Biological Psychiatry 2001; 49(6):553-555.
6. Bigelow GE, Brooner RK, Walsh SL, Preston KL, Liebson IA. Community outcomes following research exposure to cocaine or opioids. NIDA Monographs 1994; 153:354.
7. Hajak G, Muller WE, Wittchen HU, Pittrow D, Kirch W. Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: A review of case reports and epidemiological data. Addiction 2003; 98(10):1371-1378.
8. Madrak LN, Rosenberg M. Zolpidem abuse. American Journal of Psychiatry 2001; 158(8):1330-1331.
9. Rush CR, Baker RW, Wright K. Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans. Psychopharmacology 1999; 144(3):220-233.
10. Foltin RW, Haney M, Comer SD, Fischman MW. Effect of fluoxetine on food intake of humans living in a residential laboratory. Appetite 1996; 27(2):165-181.
11. Haney M, Hart CL, Vosburg SK, Nasser J, Bennett A, Zubaran C, Foltin RW. Marijuana withdrawal in humans: Effects of oral THC or divalproex. Neuropsychopharmacology 2004; 29(1):158-170.
12. Haney M, Hart CL, Ward AS, Foltin RW. Nefazodone decreases anxiety during marijuana withdrawal in humans. Psychopharmacology 2003; 165(2):157-165.
13. Hart CL, Haney M, Ward AS, Fischman MW, Foltin RW. Effects of oral THC maintenance on smoked marijuana self-administration. Drug Alcohol Depend 2002; 67(3):301-309.
14. Hart CL, Ward AS, Haney M, Foltin RW, Fischman MW. Methamphetamine self-administration by humans. Psychopharmacology (Berl) 2001; 157(1):75-81.
15. Hart CL, Ward AS, Haney M, Foltin RW. Zolpidem-related effects on performance and mood during simulated night-shift work. Experimental & Clinical Psychopharmacology 2003; 11(4):259-268.
16. McLellan AT, Luborsky L, Woody GE, O'Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The addiction severity index. Journal of Nervous & Mental Disease 1980; 168(1):26-33.